In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1186/s12885-018-4077-3 https://repositorio.unifesp.br/handle/11600/54124 |
Resumo: | Background: Aberrant methylation is a frequent event in oral cancer. Methods: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients' samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results: From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions: These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis. |
id |
UFSP_4f19f097c770d237331b68f64f939f37 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/54124 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancerOSCCGene expressionMethylationCA3FHL1Background: Aberrant methylation is a frequent event in oral cancer. Methods: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients' samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results: From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions: These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis.AC Camargo Canc Hosp, Dept Head & Neck Surg, Sao Paulo, BrazilLudwig Inst Canc Res, Lab Canc Genet, Sao Paulo, BrazilBarretos Canc Hosp, Mol Oncol Res Ctr, Barretos, BrazilEmbrapa Informat Agr, Campinas, SP, BrazilUniv Fed Sao Paulo, Discipline Hematol & Hemotherapy, UNIFESP, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Sci Biol, UNIFESP, Diadema, BrazilBarretos Canc Hosp, Dept Head & Neck Surg, Barretos, SP, BrazilUniv Fed Sao Paulo, Discipline Hematol & Hemotherapy, UNIFESP, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Sci Biol, UNIFESP, Diadema, BrazilWeb of ScienceConselho Nacional de Pesquisa (CNPq) |Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)CNPq: 476586/2006-2FAPESP: 05/02580-8Biomed Central Ltd2020-07-08T13:09:40Z2020-07-08T13:09:40Z2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttp://dx.doi.org/10.1186/s12885-018-4077-3Bmc Cancer. London, v. 18, p. -, 2018.10.1186/s12885-018-4077-3WOS000425517300002.pdf1471-2407https://repositorio.unifesp.br/handle/11600/54124WOS:000425517300002engBmc CancerLondoninfo:eu-repo/semantics/openAccessPereira, Claudia Mariade Carvalho, Ana Carolina [UNIFESP]da Silva, Felipe RodriguesMelendez, Matias EliseoLessa, Roberta CardimAndrade, Valeria Cristina C. [UNIFESP]Kowalski, Luiz PauloVettore, Andre L. [UNIFESP]Carvalho, Andre Lopesreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-11T05:25:41Zoai:repositorio.unifesp.br/:11600/54124Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-11T05:25:41Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
title |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
spellingShingle |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer Pereira, Claudia Maria OSCC Gene expression Methylation CA3 FHL1 |
title_short |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
title_full |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
title_fullStr |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
title_full_unstemmed |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
title_sort |
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer |
author |
Pereira, Claudia Maria |
author_facet |
Pereira, Claudia Maria de Carvalho, Ana Carolina [UNIFESP] da Silva, Felipe Rodrigues Melendez, Matias Eliseo Lessa, Roberta Cardim Andrade, Valeria Cristina C. [UNIFESP] Kowalski, Luiz Paulo Vettore, Andre L. [UNIFESP] Carvalho, Andre Lopes |
author_role |
author |
author2 |
de Carvalho, Ana Carolina [UNIFESP] da Silva, Felipe Rodrigues Melendez, Matias Eliseo Lessa, Roberta Cardim Andrade, Valeria Cristina C. [UNIFESP] Kowalski, Luiz Paulo Vettore, Andre L. [UNIFESP] Carvalho, Andre Lopes |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Pereira, Claudia Maria de Carvalho, Ana Carolina [UNIFESP] da Silva, Felipe Rodrigues Melendez, Matias Eliseo Lessa, Roberta Cardim Andrade, Valeria Cristina C. [UNIFESP] Kowalski, Luiz Paulo Vettore, Andre L. [UNIFESP] Carvalho, Andre Lopes |
dc.subject.por.fl_str_mv |
OSCC Gene expression Methylation CA3 FHL1 |
topic |
OSCC Gene expression Methylation CA3 FHL1 |
description |
Background: Aberrant methylation is a frequent event in oral cancer. Methods: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients' samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results: From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions: These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018 2020-07-08T13:09:40Z 2020-07-08T13:09:40Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1186/s12885-018-4077-3 Bmc Cancer. London, v. 18, p. -, 2018. 10.1186/s12885-018-4077-3 WOS000425517300002.pdf 1471-2407 https://repositorio.unifesp.br/handle/11600/54124 WOS:000425517300002 |
url |
http://dx.doi.org/10.1186/s12885-018-4077-3 https://repositorio.unifesp.br/handle/11600/54124 |
identifier_str_mv |
Bmc Cancer. London, v. 18, p. -, 2018. 10.1186/s12885-018-4077-3 WOS000425517300002.pdf 1471-2407 WOS:000425517300002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Bmc Cancer |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
- application/pdf |
dc.coverage.none.fl_str_mv |
London |
dc.publisher.none.fl_str_mv |
Biomed Central Ltd |
publisher.none.fl_str_mv |
Biomed Central Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268316915597312 |